88000887 - PROFERO

Information

  • Trademark
  • 88000887
  • Serial Number
    88000887
  • Filing Date
    June 14, 2018
    6 years ago
  • Transaction Date
    August 15, 2022
    a year ago
  • Status Date
    August 15, 2022
    a year ago
  • Published for Opposition Date
    May 14, 2019
    5 years ago
  • Location Date
    January 12, 2022
    2 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    MICKLEBURGH, LINDA BOH
  • Attorney Docket Number
    1338.16PROFE
    Attorney Name
    Bradley P. Hartman
    Law Office Assigned Location Code
    L60
  • Owners
Mark Drawing Code
4000
Mark Identification
PROFERO
Case File Statements
  • GS0051: Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting changes in genes and gene expressions for medical purposes; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of therapies; Genetic identity tests comprises of reagents for medical purposes; Clinical diagnostic preparations for medical use
  • GS0011: Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Clinical diagnostic preparations for clinical or medical laboratory use
  • TR0010: The English translation of "PROFERO" in the mark is "DELAY".
  • GS0441: Medical diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical testing, analysis, and evaluation services for medical or diagnostic purposes for providing healthcare information; Providing health care information featuring information resulting from genomic research, testing, analysis, and evaluation; Diagnosis and treatment of medical conditions, namely, of cognitive, neurological, and brain-related conditions; Providing healthcare information; Providing information in the field of disease prevention, screening, diagnosis, and treatment for medical diagnostic and treatment purposes; Medical testing services for diagnostic or treatment purposes in the medical field; Proteogenomic profiling for diagnostic or treatment purposes of cognitive, neurological, and brain-related conditions; Identification of target molecules for disease treatment, namely, treatments of cognitive, neurological, and brain-related conditions
  • GS0421: Laboratory diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development of tests and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, nucleic acid sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; Nucleic acid collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of neurology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of disease treatment and diagnosis; Medical and scientific research relating to the design and development of treatment therapies; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for research or analysis purposes; Conducting clinical and pre-clinical trials; Targeted pharmaceutical drug development services; Genotyping services for research or analysis purposes; Gene screening for research or analysis purposes; Gene isolation and gene expression analysis for scientific and medical research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research and medical purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; Nucleic acid-sequencing for scientific research purposes
Case File Event Statements
  • 8/15/2022 - a year ago
    38 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 8/15/2022 - a year ago
    37 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 1/13/2022 - 2 years ago
    36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/12/2022 - 2 years ago
    35 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 1/5/2022 - 2 years ago
    34 - SOU EXTENSION 5 FILED Type: EXT5
  • 1/12/2022 - 2 years ago
    33 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/5/2022 - 2 years ago
    32 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/6/2021 - 2 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/2/2021 - 2 years ago
    30 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 7/2/2021 - 2 years ago
    29 - SOU EXTENSION 4 FILED Type: EXT4
  • 7/2/2021 - 2 years ago
    28 - TEAS EXTENSION RECEIVED Type: EEXT
  • 12/24/2020 - 3 years ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/22/2020 - 3 years ago
    26 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 12/22/2020 - 3 years ago
    25 - SOU EXTENSION 3 FILED Type: EXT3
  • 12/22/2020 - 3 years ago
    24 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/3/2020 - 3 years ago
    23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/1/2020 - 3 years ago
    22 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 7/1/2020 - 3 years ago
    21 - SOU EXTENSION 2 FILED Type: EXT2
  • 7/1/2020 - 3 years ago
    20 - TEAS EXTENSION RECEIVED Type: EEXT
  • 12/18/2019 - 4 years ago
    19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/16/2019 - 4 years ago
    18 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/16/2019 - 4 years ago
    17 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/16/2019 - 4 years ago
    16 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/9/2019 - 4 years ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/14/2019 - 5 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/14/2019 - 5 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/24/2019 - 5 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/1/2019 - 5 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/13/2019 - 5 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/13/2019 - 5 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/11/2019 - 5 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 3/8/2019 - 5 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/10/2018 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/10/2018 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/10/2018 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/4/2018 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/20/2018 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 6/18/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP